Clinical Trial: RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder

U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07553065) titled 'RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder' on April 15.

Brief Summary: This Phase 2b study is a prospective, multicenter, double blind, randomized, placebo and sham controlled trial to assess the safety, efficacy and dose response of NT 201 delivered by the Vibe System in participants with idiopathic overactive bladder (OAB).

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Overactive Bladder (OAB)

Intervention: COMBINATION_PRODUCT: NT 201 200U and Vibe System

Combination of NT 201 200U and the ultrasound...